RDHL

시간 외 거래: .89 0.000100 +0.01%

레드힐 바이오파마 ADR (RDHL)

개요 뉴스 가격 이력 토론 예측 주식 분할

Relative Volume:

레드힐 바이오파마 ADR Stock (RDHL) Company Profile

Redhill Biopharma Ltd Adr

Healthcare (1113)

최신 SEC 제출 서류

RDHL's Discussions on Twitter

Compare RDHL vs TAK, ZTS, HLN, TEVA, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
RDHL Redhill Biopharma Ltd Adr	0.8899	4.47M	35.52M	11.39M	-26.04M	-78.99
TAK Takeda Pharmaceutical Co Adr	18.04	56.42B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.93	48.64B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.70	44.33B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	29.14	33.51B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	531.82	22.84B	3.18B	1.33B	1.04B	27.90

레드힐 바이오파마 ADR Stock (RDHL) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-08-31	개시	Cantor Fitzgerald	Overweight
2021-05-18	개시	H.C. Wainwright	Buy
2020-09-11	개시	BTIG Research	Buy
2019-07-12	업그레이드	WBB Securities	Buy → Strong Buy
2019-03-12	업그레이드	WBB Securities	Speculative Buy → Buy
2018-01-26	개시	Nomura	Buy
2017-10-06	개시	Seaport Global Securities	Buy
2017-10-04	재확인	H.C. Wainwright	Buy
2017-02-24	재확인	FBR & Co.	Outperform
2016-07-27	재확인	FBR Capital	Outperform
2015-09-29	개시	Nomura	Buy
2015-07-29	재확인	ROTH Capital	Buy
2015-06-17	재확인	H.C. Wainwright	Buy
2015-06-15	재확인	ROTH Capital	Buy

레드힐 바이오파마 ADR 주식(RDHL)의 최신 뉴스

레드힐 바이오파마 ADR (RDHL) 재무 분석

레드힐 바이오파마 ADR (RDHL)

레드힐 바이오파마 ADR Stock (RDHL) Company Profile

Compare RDHL vs TAK, ZTS, HLN, TEVA, UTHR

레드힐 바이오파마 ADR Stock (RDHL) Upgrades & Downgrades

레드힐 바이오파마 ADR 주식(RDHL)의 최신 뉴스

Adi Frish details equity holdings in RedHill Biopharma (RDHL) Form 3 - Stock Titan

RDHL Earnings History & Surprises | EPS & Revenue Results | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - ChartMill

Joint U.S. Commercialization of RedHill's Talicia® Commences - ChartMill

Joint U.S. Commercialization of RedHill's Talicia Commences - Finviz

RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase - The Globe and Mail

RDHL Stock Price, Forecast & Analysis | REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) - Chartmill

Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga

Redhill Biopharma stock soars on GLP-1 side effect treatment progress By Investing.com - Investing.com South Africa

Redhill Biopharma stock soars on GLP-1 side effect treatment progress - Investing.com India

RedHill advances once-daily ondansetron tablet for GLP-1 side effects - Investing.com

RedHill advances once-daily ondansetron tablet for GLP-1 side effects By Investing.com - Investing.com India

RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects - Finviz

RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells - Sahm

CapEx per share of RedHill Biopharma Ltd. Sponsored ADR – FWB:2RH - TradingView — Track All Markets

Redhill Biopharma Ltd. (RDHL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

RedHill Biopharma regains compliance with Nasdaq listing requirements By Investing.com - Investing.com South Africa

RedHill Biopharma regains compliance with Nasdaq listing requirements - Investing.com

RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement - Finviz

Redhill Biopharma (NASDAQ:RDHL) versus ARS Pharmaceuticals (NASDAQ:SPRY) Head-To-Head Review - Defense World

Are Smart Investors Making the Right Decision? SmartKem Inc (SMTK) - setenews.com

RedHill Biopharma increases maximum amount for at-the-market ADS offering - Investing.com

VNET Group Inc ADR (VNET) expanding its growth trajectory ahead - Setenews

Nothing is Better Than Redhill Biopharma Ltd. ADR (RDHL) stock at the moment - Setenews

RedHill Biopharma wins $10.5 million court judgment against Kukbo By Investing.com - Investing.com India

RedHill Biopharma wins $10.5 million court judgment against Kukbo - Investing.com

Redhill Biopharma stock jumps after court win against Kukbo By Investing.com - Investing.com South Africa

Redhill Biopharma stock jumps after court win against Kukbo - Investing.com India

RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement - Barchart.com

RedHill Biopharma to appeal Nasdaq compliance notice - Investing.com India

RedHill Biopharma to appeal Nasdaq compliance notice By Investing.com - Investing.com South Africa

RDHL appeals Nasdaq notice; 180-day extension possible - Stock Titan

RedHill Biopharma Receives Nasdaq Staff Determination Notification - Benzinga

RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal - PR Newswire

CID Holdco Inc (DAIC): What Does Valuation Ratios Tell Us? - fostersleader.com

Lixte Biotechnology Holdings Inc (LIXT): What Technical Indicators Show - fostersleader.com

Cumberland invests $4 million for 30% stake in RedHill’s Talicia business By Investing.com - Investing.com

RedHill Biopharma Receives Nasdaq Staff Determination Notification - Barchart.com

RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia® - Sahm

RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia - Finviz

RedHill Biopharma stock surges after court upholds $10M judgment - Investing.com

RedHill Biopharma stock surges after court upholds $10M judgment By Investing.com - Investing.com South Africa

Is RDHL Poised for Rebound? Analyzing Financial Moves - StocksToTrade

RedHill Wins New York Supreme Court Appeal, Upholding $10 Million Summary Judgment Against Kukbo - Sahm

RedHill Received Talicia® Licensing Payments Totaling $1.1 Million - PR Newswire

RedHill Biopharma receives Nasdaq extension to regain compliance by October - Investing.com

Redhill Biopharma stock soars after FDA provides positive pathway for Crohn’s drug - Investing.com

RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress - Finansavisen

RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - PR Newswire

Redhill Biopharma stock hits 52-week low at $2.47 amid steep annual decline - Investing.com

Redhill Biopharma stock hits 52-week low at $3 amid steep annual decline - Investing.com

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published - PR Newswire

레드힐 바이오파마 ADR (RDHL) 재무 분석

매출

순이익

현금흐름

주당 순 이익

RDHL과 유사한 종목